IRGFX Mutual Fund

IRGFX Mutual Fund

NAV$24.97
See how much of IRGFX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$97M
Expense Ratio
0.76%
Dividend Yield (Current)
-
Holdings
91
Inception Date
Jul 31, 2014
Fund Family
Nomura Asset Management Co Ltd
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+10.75%
1 Year+15.28%
3 Year+15.93%
5 Year+4.12%
10 Year+12.15%

Asset Allocation

Stocks: 98.83%
Cash: 1.17%
See how much of IRGFX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
TARSTarsus Pharmaceuticals Inc2.19%
WTWisdomtree Investments Inc2.17%
TVTXTravere Therapeutics Inc2.09%
EHCEmcompass Health Corporation1.99%
KTBKontoor Brands Inc1.97%
Top 10 Concentration: 19.35%Report Date: Aug 31, 2026
Download all 91 holdings for IRGFX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Latest Distribution
$6.17
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

IRGFX Mutual Fund Overview

IRGFX Mutual Fund (Nomura Small Cap Growth Fund Class R6) is managed by Nomura Asset Management Co Ltd with $97.3M in net assets. IRGFX expense ratio is 0.76%, holding 91 positions across sectors including Health Care, Information Technology, Industrials. Inception date: 2014-07-31.

IRGFX performance shows a YTD return of 10.75%. The 1-year return is 15.28% and the 5-year return is 4.12%.

IRGFX top holdings include Tarsus Pharmaceuticals Inc (2.2%), Wisdomtree Investments Inc (2.2%), Travere Therapeutics Inc (2.1%), Emcompass Health Corporation (2.0%), Kontoor Brands Inc (2.0%). Go to all IRGFX holdings, IRGFX sectors, or IRGFX dividends.

IRGFX can be compared against other funds. Use IRGFX overlap to find shared positions, or IRGFX vs another fund for a side-by-side view. IRGFX alternatives are available via the screener, along with tax-loss harvesting opportunities.